CD8A and cholangiocarcinoma: These alterations point to an active role of CD8+ Tregs in CCA and HCC physiopathology, and future studies focusing on CD8+ Tregs levels and function, analyzing in parallel the peripheral blood, peritumoral, and tumoral tissues, may be valuable to the discovery of new biomarkers and prognostic factors of these diseases.